Insider · CIK 0001884671

Autor Deborah M.

Reports to the SEC for 3 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001884671

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-18	HIMSHims & Hers Health, Inc.S Sale	Director, Chief Policy Officer	SSale	−16.8K sh	$27.85	−$467K	48,961
2026-08-14	HIMSHims & Hers Health, Inc.F Tax Payment	Director, Chief Policy Officer	FTax Payment	−16.1K sh	$28.15	−$455K	65,734
2026-08-14	HIMSHims & Hers Health, Inc.M Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	+32.9K sh	—	—	81,881
2026-08-14	HIMSHims & Hers Health, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	−32.9K sh	—	—	427,953
2026-08-12	HIMSHims & Hers Health, Inc. · Restricted Stock UnitA Award	Director, Chief Policy Officer	AAward	+8,223 sh	—	—	8,223
2026-06-15	HIMSHims & Hers Health, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	−32.9K sh	—	—	460,873
2026-06-15	HIMSHims & Hers Health, Inc.M Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	+32.9K sh	—	—	64,357
2026-06-15	HIMSHims & Hers Health, Inc.F Tax Payment	Director, Chief Policy Officer	FTax Payment	−15.4K sh	$30.17	−$464K	48,961
2026-06-11	HIMSHims & Hers Health, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	−3,656 sh	—	—	0
2026-06-11	HIMSHims & Hers Health, Inc.M Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	+3,656 sh	—	—	31,438
2026-05-11	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−34.8K sh	$12.94	−$451K	93,660
2026-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−34.8K sh	—	—	0
2026-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.8K sh	—	—	128,479
2026-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+19.8K sh	—	—	19,824
2026-03-13	HIMSHims & Hers Health, Inc.M Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	+32.9K sh	—	—	39,094
2026-03-13	HIMSHims & Hers Health, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	−32.9K sh	—	—	493,792
2026-03-13	HIMSHims & Hers Health, Inc.F Tax Payment	Director, Chief Policy Officer	FTax Payment	−11.3K sh	$24.77	−$280K	27,782
2026-03-11	HIMSHims & Hers Health, Inc. · Restricted Stock UnitA Award	Director, Chief Policy Officer	AAward	+527K sh	—	—	526,711
2025-12-17	HIMSHims & Hers Health, Inc.S Sale	Director, Chief Policy Officer	SSale	−7,054 sh	$36.71	−$259K	6,175
2025-12-15	HIMSHims & Hers Health, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	−7,054 sh	—	—	14,110
2025-12-15	HIMSHims & Hers Health, Inc.M Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	+7,054 sh	—	—	13,229
2025-08-06	HIMSHims & Hers Health, Inc. · Restricted Stock UnitA Award	Director, Chief Policy Officer	AAward	+3,656 sh	—	—	3,656
2025-06-12	HIMSHims & Hers Health, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	−6,175 sh	—	—	0
2025-06-12	HIMSHims & Hers Health, Inc.M Exercise/Conversion	Director, Chief Policy Officer	MExercise/Conversion	+6,175 sh	—	—	6,175
2025-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+34.8K sh	—	—	34,819
2025-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−40.3K sh	—	—	0
2025-05-05	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40.3K sh	—	—	93,660
2024-11-22	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−33.2K sh	$8.34	−$277K	53,402
2024-11-21	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−6,771 sh	$8.41	−$56.9K	86,631
2024-11-15	HIMSHims & Hers Health, Inc. · Restricted Stock UnitA Award	Director, Chief Policy Officer	AAward	+6,175 sh	—	—	6,175
2024-11-15	HIMSHims & Hers Health, Inc. · Restricted Stock UnitA Award	Director, Chief Policy Officer	AAward	+21.2K sh	—	—	21,164
2024-05-17	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−23.4K sh	$6.73	−$158K	93,402
2024-05-16	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−14.6K sh	$6.76	−$98.4K	116,849
2024-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−76.5K sh	—	—	0
2024-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+76.5K sh	—	—	131,402
2024-05-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+40.3K sh	—	—	40,258
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−70.4K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37.5K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37.5K sh	—	—	0
2023-07-30	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−54.9K sh	—	—	0
2023-07-30	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+54.9K sh	—	—	54,949
2023-06-01	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2023-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+76.5K sh	—	—	76,453
2022-07-29	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+54.9K sh	—	—	54,949
2022-06-08	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2021-12-23	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000

Recent filings

Accepted (ET)
Aug 204
Autor Deborah M.0001884671-26-000004
SEC(opens sec.gov)
Aug 184
Autor Deborah M.0001773751-26-000209
SEC(opens sec.gov)
Aug 144
Autor Deborah M.0001773751-26-000187
SEC(opens sec.gov)
Jun 174
Autor Deborah M.0001773751-26-000130
SEC(opens sec.gov)
Jun 154
Autor Deborah M.0001773751-26-000112
SEC(opens sec.gov)
May 124
Autor Deborah M.0001628280-26-034106
SEC(opens sec.gov)
May 84
Autor Deborah M.0001628280-26-032925
SEC(opens sec.gov)
Mar 174
Autor Deborah M.0001884671-26-000002
SEC(opens sec.gov)
Mar 134
Autor Deborah M.0001773751-26-000047
SEC(opens sec.gov)
Dec 184
Autor Deborah M.0001884671-25-000005
SEC(opens sec.gov)
Dec 164
Autor Deborah M.0001773751-25-000382
SEC(opens sec.gov)

Companies

Address

2269 CHESTNUT STREET, #523

SAN FRANCISCO, CA, 94123